Global Coronary Artery Disease Therapeutics Market Research Report 2023

Report ID: 1911597 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Coronary Artery Disease Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Beta-Blockers
        1.2.3 Calcium Channel Blockers
        1.2.4 Nitrates
        1.2.5 ACE Inhibitors
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Coronary Artery Disease Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Coronary Artery Disease Therapeutics Market Perspective (2017-2028)
    2.2 Coronary Artery Disease Therapeutics Growth Trends by Region
        2.2.1 Coronary Artery Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Coronary Artery Disease Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Coronary Artery Disease Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Coronary Artery Disease Therapeutics Market Dynamics
        2.3.1 Coronary Artery Disease Therapeutics Industry Trends
        2.3.2 Coronary Artery Disease Therapeutics Market Drivers
        2.3.3 Coronary Artery Disease Therapeutics Market Challenges
        2.3.4 Coronary Artery Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Coronary Artery Disease Therapeutics Players by Revenue
        3.1.1 Global Top Coronary Artery Disease Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Coronary Artery Disease Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Coronary Artery Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Coronary Artery Disease Therapeutics Revenue
    3.4 Global Coronary Artery Disease Therapeutics Market Concentration Ratio
        3.4.1 Global Coronary Artery Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Coronary Artery Disease Therapeutics Revenue in 2021
    3.5 Coronary Artery Disease Therapeutics Key Players Head office and Area Served
    3.6 Key Players Coronary Artery Disease Therapeutics Product Solution and Service
    3.7 Date of Enter into Coronary Artery Disease Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Coronary Artery Disease Therapeutics Breakdown Data by Type
    4.1 Global Coronary Artery Disease Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Coronary Artery Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Coronary Artery Disease Therapeutics Breakdown Data by Application
    5.1 Global Coronary Artery Disease Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Coronary Artery Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Coronary Artery Disease Therapeutics Market Size (2017-2028)
    6.2 North America Coronary Artery Disease Therapeutics Market Size by Country (2017-2022)
    6.3 North America Coronary Artery Disease Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Coronary Artery Disease Therapeutics Market Size (2017-2028)
    7.2 Europe Coronary Artery Disease Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Coronary Artery Disease Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Coronary Artery Disease Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Coronary Artery Disease Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Coronary Artery Disease Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Coronary Artery Disease Therapeutics Market Size (2017-2028)
    9.2 Latin America Coronary Artery Disease Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Coronary Artery Disease Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Coronary Artery Disease Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Coronary Artery Disease Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Coronary Artery Disease Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Coronary Artery Disease Therapeutics Introduction
        11.1.4 Pfizer Revenue in Coronary Artery Disease Therapeutics Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Coronary Artery Disease Therapeutics Introduction
        11.2.4 Novartis Revenue in Coronary Artery Disease Therapeutics Business (2017-2022)
        11.2.5 Novartis Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Detail
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Coronary Artery Disease Therapeutics Introduction
        11.3.4 GlaxoSmithKline Revenue in Coronary Artery Disease Therapeutics Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Coronary Artery Disease Therapeutics Introduction
        11.4.4 Merck Revenue in Coronary Artery Disease Therapeutics Business (2017-2022)
        11.4.5 Merck Recent Development
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Detail
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca Coronary Artery Disease Therapeutics Introduction
        11.5.4 AstraZeneca Revenue in Coronary Artery Disease Therapeutics Business (2017-2022)
        11.5.5 AstraZeneca Recent Development
    11.6 Gilead
        11.6.1 Gilead Company Detail
        11.6.2 Gilead Business Overview
        11.6.3 Gilead Coronary Artery Disease Therapeutics Introduction
        11.6.4 Gilead Revenue in Coronary Artery Disease Therapeutics Business (2017-2022)
        11.6.5 Gilead Recent Development
    11.7 Bayer
        11.7.1 Bayer Company Detail
        11.7.2 Bayer Business Overview
        11.7.3 Bayer Coronary Artery Disease Therapeutics Introduction
        11.7.4 Bayer Revenue in Coronary Artery Disease Therapeutics Business (2017-2022)
        11.7.5 Bayer Recent Development
    11.8 Bristol-Myers Squibb
        11.8.1 Bristol-Myers Squibb Company Detail
        11.8.2 Bristol-Myers Squibb Business Overview
        11.8.3 Bristol-Myers Squibb Coronary Artery Disease Therapeutics Introduction
        11.8.4 Bristol-Myers Squibb Revenue in Coronary Artery Disease Therapeutics Business (2017-2022)
        11.8.5 Bristol-Myers Squibb Recent Development
    11.9 Mylan
        11.9.1 Mylan Company Detail
        11.9.2 Mylan Business Overview
        11.9.3 Mylan Coronary Artery Disease Therapeutics Introduction
        11.9.4 Mylan Revenue in Coronary Artery Disease Therapeutics Business (2017-2022)
        11.9.5 Mylan Recent Development
    11.10 Teva Pharmaceutical Industries
        11.10.1 Teva Pharmaceutical Industries Company Detail
        11.10.2 Teva Pharmaceutical Industries Business Overview
        11.10.3 Teva Pharmaceutical Industries Coronary Artery Disease Therapeutics Introduction
        11.10.4 Teva Pharmaceutical Industries Revenue in Coronary Artery Disease Therapeutics Business (2017-2022)
        11.10.5 Teva Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Coronary Artery Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Beta-Blockers
    Table 3. Key Players of Calcium Channel Blockers
    Table 4. Key Players of Nitrates
    Table 5. Key Players of ACE Inhibitors
    Table 6. Key Players of Others
    Table 7. Global Coronary Artery Disease Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Coronary Artery Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Coronary Artery Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Coronary Artery Disease Therapeutics Market Share by Region (2017-2022)
    Table 11. Global Coronary Artery Disease Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Coronary Artery Disease Therapeutics Market Share by Region (2023-2028)
    Table 13. Coronary Artery Disease Therapeutics Market Trends
    Table 14. Coronary Artery Disease Therapeutics Market Drivers
    Table 15. Coronary Artery Disease Therapeutics Market Challenges
    Table 16. Coronary Artery Disease Therapeutics Market Restraints
    Table 17. Global Coronary Artery Disease Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Coronary Artery Disease Therapeutics Market Share by Players (2017-2022)
    Table 19. Global Top Coronary Artery Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Artery Disease Therapeutics as of 2021)
    Table 20. Ranking of Global Top Coronary Artery Disease Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Coronary Artery Disease Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Coronary Artery Disease Therapeutics Product Solution and Service
    Table 24. Date of Enter into Coronary Artery Disease Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Coronary Artery Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Coronary Artery Disease Therapeutics Revenue Market Share by Type (2017-2022)
    Table 28. Global Coronary Artery Disease Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Coronary Artery Disease Therapeutics Revenue Market Share by Type (2023-2028)
    Table 30. Global Coronary Artery Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Coronary Artery Disease Therapeutics Revenue Market Share by Application (2017-2022)
    Table 32. Global Coronary Artery Disease Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Coronary Artery Disease Therapeutics Revenue Market Share by Application (2023-2028)
    Table 34. North America Coronary Artery Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Coronary Artery Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Coronary Artery Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Coronary Artery Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Coronary Artery Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Coronary Artery Disease Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Coronary Artery Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Coronary Artery Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Coronary Artery Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Coronary Artery Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Pfizer Company Detail
    Table 45. Pfizer Business Overview
    Table 46. Pfizer Coronary Artery Disease Therapeutics Product
    Table 47. Pfizer Revenue in Coronary Artery Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 48. Pfizer Recent Development
    Table 49. Novartis Company Detail
    Table 50. Novartis Business Overview
    Table 51. Novartis Coronary Artery Disease Therapeutics Product
    Table 52. Novartis Revenue in Coronary Artery Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 53. Novartis Recent Development
    Table 54. GlaxoSmithKline Company Detail
    Table 55. GlaxoSmithKline Business Overview
    Table 56. GlaxoSmithKline Coronary Artery Disease Therapeutics Product
    Table 57. GlaxoSmithKline Revenue in Coronary Artery Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 58. GlaxoSmithKline Recent Development
    Table 59. Merck Company Detail
    Table 60. Merck Business Overview
    Table 61. Merck Coronary Artery Disease Therapeutics Product
    Table 62. Merck Revenue in Coronary Artery Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 63. Merck Recent Development
    Table 64. AstraZeneca Company Detail
    Table 65. AstraZeneca Business Overview
    Table 66. AstraZeneca Coronary Artery Disease Therapeutics Product
    Table 67. AstraZeneca Revenue in Coronary Artery Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 68. AstraZeneca Recent Development
    Table 69. Gilead Company Detail
    Table 70. Gilead Business Overview
    Table 71. Gilead Coronary Artery Disease Therapeutics Product
    Table 72. Gilead Revenue in Coronary Artery Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 73. Gilead Recent Development
    Table 74. Bayer Company Detail
    Table 75. Bayer Business Overview
    Table 76. Bayer Coronary Artery Disease Therapeutics Product
    Table 77. Bayer Revenue in Coronary Artery Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 78. Bayer Recent Development
    Table 79. Bristol-Myers Squibb Company Detail
    Table 80. Bristol-Myers Squibb Business Overview
    Table 81. Bristol-Myers Squibb Coronary Artery Disease Therapeutics Product
    Table 82. Bristol-Myers Squibb Revenue in Coronary Artery Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 83. Bristol-Myers Squibb Recent Development
    Table 84. Mylan Company Detail
    Table 85. Mylan Business Overview
    Table 86. Mylan Coronary Artery Disease Therapeutics Product
    Table 87. Mylan Revenue in Coronary Artery Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 88. Mylan Recent Development
    Table 89. Teva Pharmaceutical Industries Company Detail
    Table 90. Teva Pharmaceutical Industries Business Overview
    Table 91. Teva Pharmaceutical Industries Coronary Artery Disease Therapeutics Product
    Table 92. Teva Pharmaceutical Industries Revenue in Coronary Artery Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 93. Teva Pharmaceutical Industries Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Coronary Artery Disease Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Beta-Blockers Features
    Figure 3. Calcium Channel Blockers Features
    Figure 4. Nitrates Features
    Figure 5. ACE Inhibitors Features
    Figure 6. Others Features
    Figure 7. Global Coronary Artery Disease Therapeutics Market Share by Application in 2021 & 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Coronary Artery Disease Therapeutics Report Years Considered
    Figure 12. Global Coronary Artery Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Coronary Artery Disease Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Coronary Artery Disease Therapeutics Market Share by Region: 2021 VS 2028
    Figure 15. Global Coronary Artery Disease Therapeutics Market Share by Players in 2021
    Figure 16. Global Top Coronary Artery Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Artery Disease Therapeutics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Coronary Artery Disease Therapeutics Revenue in 2021
    Figure 18. North America Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Coronary Artery Disease Therapeutics Market Share by Country (2017-2028)
    Figure 20. United States Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Coronary Artery Disease Therapeutics Market Share by Country (2017-2028)
    Figure 24. Germany Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Coronary Artery Disease Therapeutics Market Share by Region (2017-2028)
    Figure 32. China Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Coronary Artery Disease Therapeutics Market Share by Country (2017-2028)
    Figure 40. Mexico Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Coronary Artery Disease Therapeutics Market Share by Country (2017-2028)
    Figure 44. Turkey Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Coronary Artery Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Pfizer Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2017-2022)
    Figure 48. GlaxoSmithKline Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2017-2022)
    Figure 49. Merck Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2017-2022)
    Figure 50. AstraZeneca Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2017-2022)
    Figure 51. Gilead Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2017-2022)
    Figure 52. Bayer Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2017-2022)
    Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2017-2022)
    Figure 54. Mylan Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2017-2022)
    Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Coronary Artery Disease Therapeutics Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis
GlaxoSmithKline
Merck
AstraZeneca
Gilead
Bayer
Bristol-Myers Squibb
Mylan
Teva Pharmaceutical Industries
Frequently Asked Questions
Coronary Artery Disease Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Coronary Artery Disease Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Coronary Artery Disease Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Blended Learning

Blended Learning market is segmented by players, region (country), by Type and by Application. Pl ... Read More